{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:33:52Z","timestamp":1792683232315,"version":"4.5.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["11P6X24N"],"award-info":[{"award-number":["11P6X24N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jtha.2025.02.028","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T12:36:12Z","timestamp":1741264572000},"page":"1810-1816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Discrepancy between parallel anti-Xa and activated partial thromboplastin time is related to mortality in patients with Impella-supported cardiogenic shock"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2830-624X","authenticated-orcid":false,"given":"Charlotte J.","family":"Van Edom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Fiorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Balthazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Monteagudo-Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Vanassche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios F.","family":"Panoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5151-6400","authenticated-orcid":false,"given":"Christophe","family":"Vandenbriele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.02.028_bib1","doi-asserted-by":"crossref","first-page":"e1585","DOI":"10.4244\/EIJ-D-18-00684","article-title":"Impella CP or VA-ECMO in profound cardiogenic shock: left ventricular unloading and organ perfusion in a large animal model","volume":"14","author":"M\u00f8ller-Helgestad","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jtha.2025.02.028_bib2","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJMoa2307227","article-title":"Extracorporeal life support in infarct-related cardiogenic shock","volume":"389","author":"Thiele","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.02.028_bib3","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa2312572","article-title":"Microaxial flow pump or standard care in infarct-related cardiogenic shock","volume":"390","author":"M\u00f8ller","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.02.028_bib4","first-page":"458","article-title":"European practices on antithrombotic management during percutaneous mechanical circulatory support in adults: a survey of the Association for Acute cardiovascular Care of the ESC and the European branch of the Extracorporeal Life Support Organization","volume":"13","author":"Van Edom","year":"2024","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.jtha.2025.02.028_bib5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-119-2-199307150-00002","article-title":"Establishing a therapeutic range for heparin therapy","volume":"119","author":"Brill-Edwards","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2025.02.028_bib6","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1111\/jth.15264","article-title":"APTT therapeutic range for monitoring unfractionated heparin therapy. Significant impact of the anti-Xa reagent used for correlation","volume":"19","author":"Toulon","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.02.028_bib7","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.3390\/jcm10102158","article-title":"Evaluation of anti-activated factor X activity and activated partial thromboplastin time relations and their association with bleeding and thrombosis during veno-arterial ECMO support: a retrospective study","volume":"10","author":"Moussa","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtha.2025.02.028_bib8","first-page":"e0999","volume":"5","author":"Aubron","year":"2023","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.jtha.2025.02.028_bib9","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1002\/ehf2.14816","article-title":"Discordance between aPTT and anti-Xa in monitoring heparin anticoagulation in mechanical circulatory support","volume":"11","author":"Li","year":"2024","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jtha.2025.02.028_bib10","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1365-2516.2008.01667.x","article-title":"Factor XI deficiency","volume":"14","author":"Gomez","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.02.028_bib11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-0038-1647467","article-title":"Thromboembolism and bleeding tendency in congenital factor XII deficiency - a study on 74 subjects from 14 Swiss families","volume":"65","author":"L\u00e4mmle","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.02.028_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MAT.0000000000002085","article-title":"Prevalence of FXII deficiency and its relevance to monitoring anticoagulation in adults receiving extracorporeal membrane oxygenation","volume":"70","author":"Brock","year":"2024","journal-title":"ASAIO J"},{"key":"10.1016\/j.jtha.2025.02.028_bib13","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jacc.2022.02.052","article-title":"Anticoagulation for percutaneous ventricular assist device-supported cardiogenic shock: JACC review topic of the week","volume":"79","author":"Vandenbriele","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2025.02.028_bib14","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2025.02.028_bib15","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1007\/s00134-024-07515-3","article-title":"Consumptive coagulopathy: how low-dose unfractionated heparin can prevent bleeding complications during extracorporeal life support","volume":"50","author":"Vandenbriele","year":"2024","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jtha.2025.02.028_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/jamainternmed.2022.6168","article-title":"Caution with conclusions and context of mechanical circulatory devices","volume":"183","author":"Vandenbriele","year":"2023","journal-title":"JAMA Intern Med"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625001278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625001278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T02:11:48Z","timestamp":1780279908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625001278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1538783625001278"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.02.028","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discrepancy between parallel anti-Xa and activated partial thromboplastin time is related to mortality in patients with Impella-supported cardiogenic shock","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.02.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}